Kieran Smith
Investor Relations (PCG Advisory)
Replay available
Nephros, Inc. (NEPH) Q2 2026 Earnings Call
Nephros, Inc. (NASDAQ: NEPH) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Robert Banks
President and Chief Executive Officer, NEFROS
Judy Krandel
Chief Financial Officer, NEFROS
Keaton Shokey
Analyst, Northland Capital Markets
Anthony Vendetti
Analyst, Maxim Group
John Dunn
Water Quality Manager, Trinity Health
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Nephros, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.318 -- 00:00:03.860 Good afternoon and welcome to the NEFROS, Inc. 00:00:03.860 -- 00:00:06.001 Second Quarter 2026 00:00:06.001 -- 00:00:10.744 Financial Results Conference Call. All participants will be in listen-only mode. 00:00:10.744 -- 00:00:15.426 Should you need assistance, please signal a conference specialist by pressing star then 00:00:15.426 -- 00:00:20.769 zero on your telephone keypad. After today's presentation, there will be an opportunity 00:00:20.769 -- 00:00:26.132 to ask questions. To ask a question, you may press star then one on your telephone 00:00:26.132 -- 00:00:30.775 keypad. To withdraw your question, Please press star then 2. 00:00:30.775 -- 00:00:35.640 Please note this event is being recorded. I would now like to turn the conference over 00:00:35.640 -- 00:00:41.624 to Mr. Kieran Smith, Investor Relations. Please go ahead. 00:00:42.486 -- 00:00:45.369 Thank you, Operator, and good afternoon, everyone. 00:00:45.369 -- 00:00:50.754 This is Kieran Smith with PCG Advisory. Thank you all for participating in NEFROS' 00:00:50.754 -- 00:00:53.947 second quarter 2026 conference call. 00:00:53.947 -- 00:00:57.810 Before we begin, I would like to caution that comments made during this conference call 00:00:57.810 -- 00:01:02.254 by management will contain forward-looking statements regarding the operations and future 00:01:02.254 -- 00:01:07.018 results of Nefros. I encourage you to review Nefros' filings with the Securities and 00:01:07.018 -- 00:01:12.422 Exchange Commission, including without limitation the company's Forms 10-K and 10-Q 00:01:12.422 -- 00:01:17.406 to identify specific factors that make those actual results or events to differ materially 00:01:17.406 -- 00:01:20.453 from those described in the forward-looking st...